World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
34681
World Ranking
17817
National Ranking
8889

Overview

Neal J. Meropol is affiliated with Case Western Reserve University in the United States. Their research primarily spans the field of Medicine, with a substantial focus on Oncology. Their work extends into related subfields including Economics and Econometrics, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine, and Physiology.

The scientist's research contributions include studies across several cancer-related topics. Main areas of work involve Economic and Financial Impacts of Cancer, Ethics in Clinical Research, Health Systems, Economic Evaluations, Quality of Life, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology, Palliative Care and End-of-Life Issues, and Colorectal Cancer Treatments and Studies.

Neal J. Meropol has authored numerous papers, frequently published in well-known oncology and clinical journals. Notable recent publications include:

  • Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200, 2023, Journal of Clinical Oncology
  • 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers, 2020, Cancer Research
  • Digital Health Applications in Oncology: An Opportunity to Seize, 2022, JNCI Journal of the National Cancer Institute
  • Prognostic Significance of Patient-Reported Outcomes in Cancer, 2020, JCO Oncology Practice
  • Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts, 2020, Journal of the National Comprehensive Cancer Network

The most frequent venues for their publications include:

  • Journal of Clinical Oncology
  • JCO Oncology Practice
  • JNCI Journal of the National Cancer Institute
  • Cancer Research
  • Journal of the National Comprehensive Cancer Network

Collaborations have been a significant part of their research activities. Frequent co-authors include Maneet Kaur, Smitha Krishnamurthi, Yichen Lu, Jenny S. Guadamuz, and Barry Leybovich.

Best Publications

  • Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

    Bruce J. Giantonio;Paul J. Catalano;Neal J. Meropol;Peter J. O'Dwyer

  • Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

    Fairooz Kabbinavar;Herbert I. Hurwitz;Louis Fehrenbacher;Neal J. Meropol

  • Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

    Leonard B. Saltz;Neal J. Meropol;Patrick J. Loehrer;Michael N. Needle

  • Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.

    Shirin Khambata-Ford;Christopher R. Garrett;Neal J. Meropol;Mark Basik

  • American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Courtney Tyne

  • Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

    Matthew H. Kulke;Heinz Josef Lenz;Neal J. Meropol;James Posey

  • American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

    Neal J. Meropol;Deborah Schrag;Thomas J. Smith;Therese M. Mulvey

  • Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Douglas W. Blayney

  • American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

    Martee L. Hensley;Karen L. Hagerty;Tarun Kewalramani;Daniel M. Green

  • Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.

    S.J. Cohen;C.J.A. Punt;N. Iannotti;B.H. Saidman

  • Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

    Andrew L. Pecora;Naiyer Rizvi;Gary I. Cohen;Neal J. Meropol

  • American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

    Martee L. Hensley;Lynn M. Schuchter;Celeste Lindley;Neal J. Meropol

  • American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes

    Lee M. Ellis;David S. Bernstein;Emile E. Voest;Jordan D. Berlin

  • High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200

    B. J. Giantonio;P. J. Catalano;N. J. Meropol;P. J. O'Dwyer

  • Cost of Cancer Care: Issues and Implications

    Neal J. Meropol;Kevin A. Schulman

  • Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1

    Anthony W. Tolcher;Monica Mita;Neal J. Meropol;Margaret von Mehren

  • Centralization of Cancer Surgery: Implications for Patient Access to Optimal Care

    Karyn B. Stitzenberg;Elin R. Sigurdson;Brian L. Egleston;Russell B. Starkey

  • Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial

    Brian N. Stein;Nicholas J. Petrelli;Harold O. Douglass;Deborah L. Driscoll

  • UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

    Leslie E. Carlini;Neal J. Meropol;John Bever;Michael L. Andria

  • The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer

    Richard M. Goldberg;Mace L. Rothenberg;Eric Van Cutsem;Al B. Benson

Frequent Co-Authors

Al B. Benson
Al B. Benson Northwestern University
Kevin A. Schulman
Kevin A. Schulman Stanford University
Sharon L. Manne
Sharon L. Manne Rutgers, The State University of New Jersey
Louis M. Weiner
Louis M. Weiner Georgetown University Medical Center
Suzanne M. Miller
Suzanne M. Miller Fox Chase Cancer Center
Cary P. Gross
Cary P. Gross Yale University
Jordan Berlin
Jordan Berlin Vanderbilt University Medical Center
Mary F. Mulcahy
Mary F. Mulcahy Northwestern University
Gary H. Lyman
Gary H. Lyman Fred Hutchinson Cancer Research Center
Michael W. Kattan
Michael W. Kattan Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring alternatives or stepping stones to studying Medicine in the USA, there are numerous online degrees and career pathways that offer flexibility and affordability. Many students begin their healthcare careers through nursing, which has a range of accessible and expedited educational options.

If you’re aiming for advanced practice or leadership roles, an online PhD nursing program allows you to study at the highest academic level from anywhere, often at a fraction of the cost of traditional programs. Those currently working as registered nurses can opt for rn to bsn cheapest programs to enhance credentials and open new career doors.

Non-nurses interested in quickly entering the field should consider cheapest direct entry msn programs. These programs offer accelerated pathways to a master's degree and a new career in nursing. Additionally, aspiring students looking for straightforward admissions can explore direct admit nursing programs, which provide an easier entry point into competitive healthcare education.

Exploring these alternatives ensures prospective students can find a pathway best suited to their career goals, budget, and timeline within the expansive field of healthcare.

Best Scientists Citing Neal J. Meropol

Trending Scientists